Bruker Corp Q3 2020 Earnings Call Summary

Edited Brief of BRKR.OQ earnings conference call or presentation 2-Nov-20 9:30pm GMT

...A. Highlights: Co. continues to navigate a challenging environment among a global pandemic. 1. While the majority of Co.'s academic and research customers worldwide have returned to business under a new normal, some still operate at productivity levels that are below pre-pandemic levels in an effort to accommodate safety protocols. a. b. Against this backdrop, Co. delivered a good 3Q with sequentially strengthened financial performance vs. first two quarters of 2020. 2. Revenue declined slightly YoverY, but non-GAAP operating margins and non-GAAP EPS improved significantly vs. 2Q20 or 1Q20 and approached prior year 3Q19 levels. 3. During 3Q, Co. continued to support initiatives to understand SARS-CoV-2 virus and COVID-19 disease. These include functional structural biology studies by high field NMR, so called long COVID patient studies by NMR and mass spec metabolomics and viral protein and disease patient proteomics research by mass spectrometry. a. b. Co. supports the discovery and development...

Brief